GE HealthCare Technologies Inc. $GEHC Stock Holdings Lessened by Nan Fung Trinity HK Ltd.

Nan Fung Trinity HK Ltd. trimmed its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 51.0% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 451,375 shares of the company’s stock after selling 470,350 shares during the quarter. GE HealthCare Technologies comprises about 2.8% of Nan Fung Trinity HK Ltd.’s investment portfolio, making the stock its 13th largest position. Nan Fung Trinity HK Ltd.’s holdings in GE HealthCare Technologies were worth $29,506,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Northside Capital Management LLC raised its position in GE HealthCare Technologies by 26.5% during the 2nd quarter. Northside Capital Management LLC now owns 241,923 shares of the company’s stock valued at $15,485,000 after purchasing an additional 50,634 shares during the last quarter. Hsbc Holdings PLC lifted its holdings in GE HealthCare Technologies by 22.8% in the 2nd quarter. Hsbc Holdings PLC now owns 1,004,490 shares of the company’s stock worth $64,217,000 after buying an additional 186,800 shares during the period. TD Waterhouse Canada Inc. lifted its holdings in GE HealthCare Technologies by 5.1% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 608,890 shares of the company’s stock worth $39,015,000 after buying an additional 29,752 shares during the period. Trian Fund Management L.P. lifted its holdings in GE HealthCare Technologies by 76,194.4% in the 2nd quarter. Trian Fund Management L.P. now owns 3,085,344 shares of the company’s stock worth $197,493,000 after buying an additional 3,081,300 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of GE HealthCare Technologies by 0.8% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,541,393 shares of the company’s stock worth $162,675,000 after buying an additional 20,180 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

GEHC has been the topic of several research analyst reports. Wall Street Zen raised GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, October 31st. Needham & Company LLC restated a “buy” rating and set a $93.00 target price on shares of GE HealthCare Technologies in a report on Monday, October 5th. Piper Sandler reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a research note on Wednesday, July 29th. Evercore reaffirmed an “outperform” rating and issued a $84.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. Finally, Citigroup lifted their price target on shares of GE HealthCare Technologies from $71.00 to $79.00 and gave the company a “neutral” rating in a report on Thursday, October 29th. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $82.17.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $81.84 on Friday. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77. The stock has a market capitalization of $37.00 billion, a P/E ratio of 17.27, a P/E/G ratio of 2.08 and a beta of 0.65. The company’s 50-day moving average is $70.29 and its 200 day moving average is $70.10. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.30 and a quick ratio of 1.01.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 28th. The company reported $1.34 EPS for the quarter, topping the consensus estimate of $1.20 by $0.14. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The business had revenue of $5.51 billion during the quarter, compared to analyst estimates of $5.35 billion. During the same period last year, the business posted $1.07 earnings per share. GE HealthCare Technologies’s quarterly revenue was up 7.2% compared to the same quarter last year. On average, sell-side analysts expect that GE HealthCare Technologies Inc. will post 5.02 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be given a $0.04 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s dividend payout ratio is currently 3.38%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.